J&J: presenting series of abstracts on myasthenia gravis

(CercleFinance.com) - Johnson & Johnson announces that 25 abstracts will be presented at two medical events (i.
e., American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA), on 15-18 October 2024) concerning generalized myasthenia gravis (gMG) and the evaluation of the investigational treatment nipocalimab.

Sixteen of these abstracts will be shared at the MGFA Scientific Session, including three oral presentations on nipocalimab.

These studies show positive results in adolescents and adults with gMG, with early and lasting improvements.

The presentations also address the impact of the disease on daily life and the challenges of managing gMG.


Copyright (c) 2024 CercleFinance.com. All rights reserved.